David Monson, M.D.
Assistant Professor of Orthopaedic Surgery
Emory University School of Medicine
Chief of Orthopaedic Surgery
Emory University Hospital Midtown
Additional Contact Information
Emory Orthopaedics & Spine Center
59 Executive Park South
Atlanta, GA 30329
- Medical School, University of Iowa School of Medicine, Iowa City, IA , 1982
- Internship, University of Wisconsin Hospital & Clinic, 1983
- Residency, University of Wisconsin Hospital & Clnic, 1987
- Fellowship, University of Chicago Medical Center, Chicago, IL, 1988
Dr. Monson started practicing at Emory in 1988. He is an expert in the treatment of rare tumors (sarcomas of the bone and soft tissue). He and his partner, Shervin V. Oskouei, MD, head The Emory Musculoskeletal Oncology and Limb Reconstruction Center, a world-class center treating a variety of conditions, including benign and malignant tumors of the extremities and spine. Together, they offer a combined 25 years of clinical practice experience.
Dr. Monson is intimately involved with the education of future physicians at the medical school, residency, and fellowship level. Combining his experience and interests with the state-of-the-art facilities of Emory University and the Winship Cancer Institute of Emory University allows Dr. Monson to treat patients with the latest modalities using a multidisciplinary approach.
Dr. Monson is involved with numerous projects involving musculoskeletal tumors. In collaboration with the Winship Cancer Institute, his team is looking at specific markers to develop drugs against sarcomas and is establishing a database of sarcomas at Emory. The center is currently involved in numerous basic science and clinical studies, including various phase 1 and phase 2 trials.
Dr. Monson’s research focus is primarily related to clinical projects concerning patients with bone and soft tissue tumors. His interests lie particularly in characterizing pre-referral practice patterns of referring physicians such as the performance of specific types of imaging or surgeries prior to the establishment of the diagnosis of a bone or soft tissue sarcoma. Clinical outcomes in the treatment of giant cell tumors of bone, survivorship of prosthetic bone reconstructions, and potential immune responses to bone allograft materials are also being undertaken.
Honors and Awards
- State of Iowa Scholar, 1974
- Phi Eta Sigma, 1975
- College of Sciences and Humanities, Highest 2%, 1975, 1978
- Haywood-Goodspeed Award, Department of Biochemistry and Biophysics, Iowa State University, 1976, 1977, 1978
- Phi Kappa Phi, 1978
- Phi Beta Kappa, 1978
- Alpha Omega Alpha, 1981
- View publications on PubMed